Kintara Therapeutics

-$0.0016 (-0.99%) As of 1:50 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KTRA and other ETFs, options, and stocks.

About KTRA

Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. It focuses on VAL-083 and REM-001 pipelines.

CEO
Robert E. Hoffman
Employees
20
Headquarters
San Diego, California
Founded
2009

KTRA Key Statistics

Market cap
10.62M
Price-Earnings ratio
—
Dividend yield
—
Average volume
4.49M
High today
$0.163
Low today
$0.1579
Open price
$0.1597
Volume
420.49K
52 Week high
$2.85
52 Week low
$0.1406

KTRA Earnings

-$0.36
-$0.24
-$0.12
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
— per share
Actual
-$0.11 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure